European Pharma Finally Becomes a Health Matter
Having been the responsibility of the European Commission's DG Enterprise and Industry for many years, pharmaceutical policy in the EU is to be switched to the Health and Consumer Policy directorate, DG Sanco, at the beginning of 2010.
Responsibility for the European Medicines Agency (EMEA, which will now be abbreviated as EMA) will be included in the portfolio of the new Health Commissioner John Dalli, who currently serves as the Minister for Social Policy in Malta.
However, Pharm Exec Europe's Brussels correspondent, Reflector, highlighted a point of concern. "Bringing the industry into the ambit of health and consumer affairs will leave it exposed to — and largely undefended from — the views of policymakers," he said. "They focus principally on medicines as a social good, and tend to ignore the industrial imperatives that underlie the exercise of making medicines available."
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety